Atlas Trials

Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea

Clinical trial NCT04106726 · COMPLETED

Trial details

NCT number
NCT04106726
Sponsor
Zydus Worldwide DMCC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Facial Rosacea
Start date
2019-10-17
Primary completion
2020-08-04
Enrollment
525

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.